Welcome to Medications.com

Lithobid News

Noven Appoints Michael D. Price Chief Financial Officer - Genetic Engineering News (press release)

Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...

http://www.genengnews.com/news/bn... | Posted: Thu Nov 15 17:37:23 -0500 2007

Noven Announces Share Repurchase Program - PharmaLive.com (press release)

Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...

http://www.medadnews.com/News/Ind... | Posted: Wed Sep 05 05:54:13 -0400 2007

Noven to pay $125M for JDS - Washington Business Journal

... panic disorder, obsessive-compulsive disorder and generalized anxiety disorder) and Lithobid (for bipolar disorder and related manic episodes) to hit ...

http://washington.bizjournals.com... | Posted: Wed Jul 11 11:24:15 -0400 2007

Emmis Communications Turns To Loss In Q1 On Softness In Radio ... - RTT News

Looking ahead to the second half of 2007, Noven expects net sales of Pexeva and Lithobid of $14 million and the company would recognize approximately $12 ...

http://www.rttnews.com/sp/breakin... | Posted: Tue Jul 10 04:48:00 -0400 2007

Noven to buy JDS Pharma, sees big charge - Reuters.uk

JDS sells Lithobid for bipolar disorder and Pexeva for depression, panic disorder and obsessive-compulsive disorder. It has applied to market the capsule ...

http://investing.reuters.co.uk/in... | Posted: Tue Jul 10 07:20:39 -0400 2007

Noven Pharma To Acquire JDS Pharma For $125 Mln In Cash; Forecast ... - RTT News

Looking ahead to the second half of 2007, Noven expects net sales of Pexeva and Lithobid of $14 million and the company would recognize approximately $12 ...

http://www.rttnews.com/sp/breakin... | Posted: Tue Jul 10 03:20:44 -0400 2007

Noven acquires JDS to transform business outlook - US-PharmaTechnologist.com

In addition, the JDS acquisition will add Lithobid, the only branded lithium carbonate product sold in the US for bipolar disorder to Noven's portfolio. ...

http://us-pharmatechnologist.com/... | Posted: Wed Jul 11 16:32:49 -0400 2007

Noven to pay $125M for JDS - MLive.com

... panic disorder, obsessive-compulsive disorder and generalized anxiety disorder) and Lithobid (for bipolar disorder and related manic episodes) to hit ...

http://www.mlive.com/business/amb... | Posted: Wed Jul 11 01:42:30 -0400 2007

Noven to buy JDS Pharma for $125 million - BusinessWeek

New York City-based JDS markets two branded prescription psychiatry products, Lithobid and Pexeva for bipolar disporder and depression, respectively. ...

http://www.businessweek.com/ap/fi... | Posted: Tue Jul 10 04:02:41 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea